Mechanistically, IDO1high cancer cell-derived EVs raised nicotinamide adenine dinucleotide (NAD +) levels in endothelial cells by transferring L-kyn and also upregulated sirt3 expression in endothelial cells through regulating acetylation modification. The gene discussed is SIRT3; the disease is cancer.